Lung Cancer Trial, Recruiting (NCT06807307)

Lung Cancer Trial, Recruiting NCT06807307 Sponsor: Regina Elena Cancer Institute Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06807307 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are older than 18 years of age
You have been diagnosed with non-small cell lung cancer (a specific type of lung cancer), confirmed through a tissue sample
Your cancer has spread to other parts of the body (metastatic disease)
A tissue sample taken before any cancer treatment (such as chemotherapy or radiotherapy) is available and suitable for laboratory testing
Your general health and ability to carry out daily activities falls within an acceptable range (confirm with trial site)
Your blood counts and kidney and liver function are at adequate levels (confirm with trial site)
Your cancer can be measured using standard imaging methods
Follow-up health information is available for at least 6 months and/or until the cancer progresses or death (this may apply to one group of participants only — confirm with trial site)
You are willing and able to give written consent to take part and for your data to be used

Who may not be able to join:

You have already received systemic treatment (such as chemotherapy or targeted drug therapy) for your metastatic cancer
You have other serious health conditions that are not well managed with medication

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06807307

Sponsor: Regina Elena Cancer Institute

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

More information: https://clinicaltrials.gov/study/NCT06807307

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are older than 18 years of age
You have been diagnosed with non-small cell lung cancer (a specific type of lung cancer), confirmed through a tissue sample
Your cancer has spread to other parts of the body (metastatic disease)
A tissue sample taken before any cancer treatment (such as chemotherapy or radiotherapy) is available and suitable for laboratory testing
Your general health and ability to carry out daily activities falls within an acceptable range (confirm with trial site)
Your blood counts and kidney and liver function are at adequate levels (confirm with trial site)
Your cancer can be measured using standard imaging methods
Follow-up health information is available for at least 6 months and/or until the cancer progresses or death (this may apply to one group of participants only — confirm with trial site)
You are willing and able to give written consent to take part and for your data to be used

Who may not be able to join:

You have already received systemic treatment (such as chemotherapy or targeted drug therapy) for your metastatic cancer
You have other serious health conditions that are not well managed with medication

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Regina Elena Cancer Institute

Registry

ClinicalTrials.gov

Start date

4 June 2024

Est. completion

4 June 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Innovative molecular tool

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov